Postmenopausal hormone therapy for prevention of fractures - How good is the evidence?

被引：36

作者：

Grady, D

Cummings, SR

机构：

[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA

[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 285卷 / 22期

关键词：

D O I：

10.1001/jama.285.22.2909

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2909 / 2910

页数：2

共 18 条

[1]

Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0

[2] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[3] Effects of hormone therapy on bone mineral density - Results from the postmenopausal estrogen/progestin interventions (PEPI) trial [J].

Bush, TL ;

Wells, HB ;

James, MK ;

BarrettConnor, E ;

Marcus, R ;

Greendale, G ;

Hunsberger, S ;

McGowan, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17) :1389-1396

[4] ESTROGEN REPLACEMENT THERAPY AND FRACTURES IN OLDER WOMEN [J].

CAULEY, JA ;

SEELEY, DG ;

ENSRUD, K ;

ETTINGER, B ;

BLACK, D ;

CUMMINGS, SR .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (01) :9-16

[5] Effects of hormone replacement therapy on clinical fractures and height loss: The heart and estrogen/progestin replacement study (HERS) [J].

Cauley, JA ;

Black, DM ;

Barrett-Connor, E ;

Harris, F ;

Shields, K ;

Applegate, W ;

Cummings, SR .

AMERICAN JOURNAL OF MEDICINE, 2001, 110 (06) :442-450

[6] A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study [J].

Chesnut, CH ;

Silverman, S ;

Andriano, K ;

Genant, H ;

Gimona, A ;

Harris, S ;

Kiel, D ;

LeBoff, M ;

Maricic, M ;

Miller, P ;

Moniz, C ;

Peacock, M ;

Richardson, P ;

Watts, N ;

Baylink, D .

AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :267-276

[7] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].

Cummings, SR ;

Black, DM ;

Thompson, DE ;

Applegate, WB ;

Barrett-Connor, E ;

Musliner, TA ;

Palermo, L ;

Prineas, R ;

Rubin, SM ;

Scott, JC ;

Vogt, T ;

Wallace, R ;

Yates, AJ ;

LaCroix, AZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082

[8] Effect of calcium and vitamin D supplementation on bone, density in men and women 65 years of age or older [J].

DawsonHughes, B ;

Harris, SS ;

Krall, EA ;

Dallal, GE .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) :670-676

[9] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[10] Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study [J].

Grady, D ;

Wenger, NK ;

Herrington, D ;

Khan, S ;

Furberg, C ;

Hunninghake, D ;

Vittinghoff, E ;

Hulley, S .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :689-+

← 1 2 →